d*r
2 楼
RNA一大早跌了80%..
http://www.businessweek.com/news/2013-09-20/prosensa-shares-plu
Bloomberg News
Prosensa Shares Plunge as Muscular Dystrophy Drug Fails in Trial
By Makiko Kitamura September 20, 2013
Prosensa Holding NV (RNA:US) plunged after the Dutch company’s experimental
muscular dystrophy drug failed to help patients walk better in a clinical
trial.
Prosensa sank 71 percent to $7 at 7:55 a.m. New York time in trading (RNA:US
) before U.S. exchanges opened. The company is based in Leiden, the
Netherlands, and listed on the Nasdaq Stock Market. Prosensa is developing
the treatment, drisapersen, with GlaxoSmithKline Plc. (GSK)
Drisapersen failed to help patients more than a placebo in a test of six-
minute walking distance, the companies said in a statement today.
STORY: Former Lehman CFO Erin Callan's Never Going Back
Duchenne muscular dystrophy is a neuromuscular disease with no known cure
that affects one in 3,500 newborn boys.
Glaxo rose 0.1 percent to 1,578 pence in London. Sarepta Therapeutics Inc.
is developing a competing drug.
Prosensa sold shares in June in an initial public offering (RNA:US) at $13
each. The company had a market value of $840.1 million based on yesterday’s
closing share price of $24.
http://www.businessweek.com/news/2013-09-20/prosensa-shares-plu
Bloomberg News
Prosensa Shares Plunge as Muscular Dystrophy Drug Fails in Trial
By Makiko Kitamura September 20, 2013
Prosensa Holding NV (RNA:US) plunged after the Dutch company’s experimental
muscular dystrophy drug failed to help patients walk better in a clinical
trial.
Prosensa sank 71 percent to $7 at 7:55 a.m. New York time in trading (RNA:US
) before U.S. exchanges opened. The company is based in Leiden, the
Netherlands, and listed on the Nasdaq Stock Market. Prosensa is developing
the treatment, drisapersen, with GlaxoSmithKline Plc. (GSK)
Drisapersen failed to help patients more than a placebo in a test of six-
minute walking distance, the companies said in a statement today.
STORY: Former Lehman CFO Erin Callan's Never Going Back
Duchenne muscular dystrophy is a neuromuscular disease with no known cure
that affects one in 3,500 newborn boys.
Glaxo rose 0.1 percent to 1,578 pence in London. Sarepta Therapeutics Inc.
is developing a competing drug.
Prosensa sold shares in June in an initial public offering (RNA:US) at $13
each. The company had a market value of $840.1 million based on yesterday’s
closing share price of $24.
x*n
3 楼
我上上周team member说马上安排onsite,结果上周没消息,这周到现在还没消息。
w*x
6 楼
明天问吧,表现得积极一点。good luck。
f*i
7 楼
打电话问了HR,说还没有安排,又给HM发了邮件骚扰,继续漫长的等待。。。
我人生中最美好的时间都在等待中过去了。。。
我人生中最美好的时间都在等待中过去了。。。
相关阅读
东西岸哪个牛校附近生活费低啊关于Error bar的问题Biggest Advancement in the Bio/Biotech field in recent years (1-2y)?如何dig out一个蛋白的潜在isoform求metamorph 生物分析软件!用于particle tracking analysis急求三篇文章,不胜感激~~~~~~~~~Looking for a HA antibody working for whole mount immune staining?寻求对Mitochondira很熟悉的合作者Where to buy Bacterial Genes?知识改变命运作假撤稿Which cell type for cell transformation assay is the best?之前被拒,这两天又看到在招人,还要不要申?工程院院士 杨宝峰 两篇 JBC被撤稿这个发过了没?How people in science see each other求助:请问那里可以买到植物病毒中科院公布145位院士初步候选人 饶毅出局Cancer 方面的5点左右的杂志那个容易投点?请问有知道Chi Van Dang的lab如何?求推荐Cycloheximide